Ionic Regulation of Cell Volume Changes and Cell Death after Ischemic Stroke

Translational Stroke Research

Volumn 5, Issue 1, 2014, Pages 17-27

  Song, Mingke ^a   Yu, Shan Ping ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell volume regulation; Hybrid cell death; Ionic mechanism; Potassium channels; Sodium pump; Stroke

Indexed keywords

ACID SENSING ION CHANNEL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMPA RECEPTOR; GAP JUNCTION PROTEIN; ION; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ3; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL CULTURE; CELL DEATH; CELL ENERGY; CELL SWELLING; CELL VOLUME; CYTOTOXICITY; ENZYME DEFECT; HOMEOSTASIS; HUMAN; HYBRID CELL; MOLECULAR DYNAMICS; NONHUMAN; POTASSIUM BALANCE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CELL SIZE; HUMANS; ION CHANNELS; MEMBRANE PROTEINS; STROKE;

EID: 84893749921     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-013-0314-x     Document Type: Article

References (133)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127: e6-e245.
2. Yap E, Tan WL, Ng I, Ng YK. Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit? Brain Res. 2008;1195: 130-8.
3. Baille V, Clarke PG, Brochier G, Dorandeu F, Verna JM, Four E, et al. Soman-induced convulsions: the neuropathology revisited. Toxicology. 2005;215: 1-24.
4. Gladstone DJ, Black SE, Hakim AM. Heart, and Stroke Foundation of Ontario Centre of Excellence in Stroke, R., Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33: 2123-36.
5. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2009;40: S111-4.
6. Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci. 2012;13: 11753-72.
7. Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C. Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke. 2012;7: 407-18.
8. Goldberg MP, Ransom BR. New light on white matter. Stroke. 2003;34: 330-2.
9. Arakawa S, Wright PM, Koga M, Phan TG, Reutens DC, Lim I, et al. Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke. 2006;37: 1211-6.
10. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27: 1641-6. discussion 1647.
11. Di Lisa F. Mitochondrial contribution in the progression of cardiac ischemic injury. IUBMB Life. 2001;52: 255-61.
12. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4: 399-415.
13. Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. 2012;7: 378-85.
14. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10: 861-72.
15. Ramana MV, Nandikar M, Gurav RV, Johny Kumar T, Sanjappa M. Murdannia saddlepeakensis (Commelinaceae)-a new species from Andaman and Nicobar Islands, India. PhytoKeys. 2013; 9-15.
16. 2+ exchanger. Mol Cell Biochem. 1998;188: 187-97.
17. Garcia JH, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J, et al. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol. 1993;142: 623-35.
18. Nukada H, Dyck PJ. Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination. Ann Neurol. 1987;22: 311-8.
19. 2+ exchange currents in cortical neurons: concomitant forward and reverse operation and effect of glutamate. Eur J Neurosci. 1997;9: 1273-81.
20. Cuomo O, Gala R, Pignataro G, Boscia F, Secondo A, Scorziello A, et al. A critical role for the potassium-dependent sodium-calcium exchanger NCKX2 in protection against focal ischemic brain damage. J Neurosci. 2008;28: 2053-63.
21. 2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage. J Neurosci. 2008;28: 1179-84.
22. Jeffs GJ, Meloni BP, Sokolow S, Herchuelz A, Schurmans S, Knuckey NW. NCX3 knockout mice exhibit increased hippocampal CA1 and CA2 neuronal damage compared to wild-type mice following global cerebral ischemia. Exp Neurol. 2008;210: 268-73.
23. Jeffs GJ, Meloni BP, Bakker AJ, Knuckey NW. The role of the Na(+)/Ca(2+) exchanger (NCX) in neurons following ischaemia. J Clin Neurosci. 2007;14: 507-14.
24. Gomez-Angelats M, Bortner CD, Cidlowski JA. Cell volume regulation in immune cell apoptosis. Cell Tissue Res. 2000;301: 33-42.
25. Nunez R, Sancho-Martinez SM, Novoa JM, Lopez-Hernandez FJ Apoptotic volume decrease as a geometric determinant for cell dismantling into apoptotic bodies. Cell Death Differ. 17: 1665-71.
26. Bortner CD, Cidlowski JA. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol. 1998;56: 1549-59.
27. Ranjbar E, Shams J, Sabetkasaei M, M MS, Rashidkhani B, Mostafavi A, Bornak E, Nasrollahzadeh J. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci. 2013.
28. Rich A, Gordon S, Brown C, Gibbons SJ, Schaefer K, Hennig G, et al. Kit signaling is required for development of coordinated motility patterns in zebrafish gastrointestinal tract. Zebrafish. 2013;10: 154-60.
29. de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS, et al. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2: e000092.
30. + channels: an essential pathway in programmed cell death. Am J Physiol Lung Cell Mol Physiol. 2004;286: L49-67.
31. Xie Y, Zacharias E, Hoff P, Tegtmeier F. Ion channel involvement in anoxic depolarization induced by cardiac arrest in rat brain. J Cereb Blood Flow Metab. 1995;15: 587-94.
32. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001;81: 1065-96.
33. Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab. 1993;13: 568-74.
34. Zhang X, Lee TH, Davidson C, Lazarus C, Wetsel WC, Ellinwood EH. Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. Neuropsychopharmacology. 2007;32: 377-87.
35. G N, P VA, A RS, R R, M S, R S. Role of TSH on urinary calcium excretion in post menopausal women of South Indian population. J Clin Diagn Res. 2013;7: 1099-101.
36. Burg ED, Remillard CV, Yuan JX. Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol. 2008;153 Suppl 1: S99-S111.
37. Hughes Jr FM, Cidlowski JA. Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv Enzyme Regul. 1999;39: 157-71.
38. Xiao AY, Homma M, Wang XQ, Wang X, Yu SP. Role of K(+) efflux in apoptosis induced by AMPA and kainate in mouse cortical neurons. Neuroscience. 2001;108: 61-7.
39. Choi DW. Possible mechanisms limiting N-methyl-d-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-d-aspartate antagonists. Stroke. 1990;21: III20-2.
40. Kwak S, Weiss JH. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol. 2006;16: 281-7.
41. Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci U S A. 2009;106: 9854-9.
42. Rodriguez IA, Fernandez-Segura E, Ceballos G, Arrebola F, del Carmen Sanchez-Quevedo M, Campos A. Hybrid cell death induced by exposure to 2-hydroxyethyl methacrylate (HEMA): an ultrastructural and X-ray microanalytical study. J Adhes Dent. 2008;10: 105-11.
43. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci U S A. 1998;95: 10229-34.
44. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci. 2000;20: 1190-8.
45. Domercq M, Etxebarria E, Perez-Samartin A, Matute C. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia. 2005;52: 36-46.
46. Tekkok SB, Goldberg MP. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci. 2001;21: 4237-48.
47. Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem. 1995;64: 2442-8.
48. Sanchez-Gomez MV, Matute C. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol Dis. 1999;6: 475-85.
49. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med. 1998;4: 291-7.
50. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci. 2000;20: 9235-41.
51. Ouardouz M, Coderre E, Basak A, Chen A, Zamponi GW, Hameed S, et al. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann Neurol. 2009;65: 151-9.
52. Ouardouz M, Coderre E, Zamponi GW, Hameed S, Yin X, Trapp BD, et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann Neurol. 2009;65: 160-6.
53. Berger T, Walz W, Schnitzer J, Kettenmann H. GABA- and glutamate-activated currents in glial cells of the mouse corpus callosum slice. J Neurosci Res. 1992;31: 21-7.
54. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron. 1994;12: 357-71.
55. Liu HN, Almazan G. Glutamate induces c-fos proto-oncogene expression and inhibits proliferation in oligodendrocyte progenitors: receptor characterization. Eur J Neurosci. 1995;7: 2355-63.
56. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature. 2005;438: 1162-6.
57. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature. 2005;438: 1167-71.
58. Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature. 2006;439: 988-92.
59. Besancon E, Guo S, Lok J, Tymianski M, Lo EH. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci. 2008;29: 268-75.
60. + channel. J Biol Chem. 1996;271: 7879-82.
61. Chen CC, England S, Akopian AN, Wood JN. A sensory neuron-specific, proton-gated ion channel. Proc Natl Acad Sci U S A. 1998;95: 10240-5.
62. Price MP, Lewin GR, McIlwrath SL, Cheng C, Xie J, Heppenstall PA, et al. The mammalian sodium channel BNC1 is required for normal touch sensation. Nature. 2000;407: 1007-11.
63. Wemmie JA, Chen J, Askwith CC, Hruska-Hageman AM, Price MP, Nolan BC, et al. The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory. Neuron. 2002;34: 463-77.
64. Wemmie JA, Askwith CC, Lamani E, Cassell MD, Freeman Jr JH, Welsh MJ. Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning. J Neurosci. 2003;23: 5496-502.
65. Nedergaard M, Kraig RP, Tanabe J, Pulsinelli WA. Dynamics of interstitial and intracellular pH in evolving brain infarct. Am J Physiol. 1991;260: R581-8.
66. Wemmie JA, Taugher RJ, Kreple CJ. Acid-sensing ion channels in pain and disease. Nat Rev Neurosci. 2013;14: 461-71.
67. Vergo S, Craner MJ, Etzensperger R, Attfield K, Friese MA, Newcombe J, et al. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain. 2011;134: 571-84.
68. Marmarou A. Intracellular acidosis in human and experimental brain injury. J Neurotrauma. 1992;9 Suppl 2: S551-62.
69. Li M, Inoue K, Branigan D, Kratzer E, Hansen JC, Chen JW, et al. Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J Cereb Blood Flow Metab. 2010;30: 1247-60.
70. Wemmie JA, Price MP, Welsh MJ. Acid-sensing ion channels: advances, questions and therapeutic opportunities. Trends Neurosci. 2006;29: 578-86.
71. Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, Wei WL, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell. 2004;118: 687-98.
72. Gao J, Duan B, Wang DG, Deng XH, Zhang GY, Xu L, et al. Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death. Neuron. 2005;48: 635-46.
73. + channel on ischemia-sensing neurons. Nat Neurosci. 2001;4: 869-70.
74. 2+, and acidosis-mediated neuronal injury by intracellular pH. J Biol Chem. 2006;281: 29369-78.
75. Pignataro G, Simon RP, Xiong ZG. Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. Brain. 2007;130: 151-8.
76. Gu L, Yang Y, Sun Y, Zheng X. Puerarin inhibits acid-sensing ion channels and protects against neuron death induced by acidosis. Planta Med. 2010;76: 583-8.
77. Chang Y, Hsieh CY, Peng ZA, Yen TL, Hsiao G, Chou DS, et al. Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats. J Biomed Sci. 2009;16: 9.
78. Zhang Y, Zhou L, Zhang X, Bai J, Shi M, Zhao G. Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia. Neurol Sci. 2012;33: 1125-31.
79. Yifeng M, Bin W, Weiqiao Z, Yongming Q, Bing L, Xiaojie L. Neuroprotective effect of sophocarpine against transient focal cerebral ischemia via down-regulation of the acid-sensing ion channel 1 in rats. Brain Res. 2011;1382: 245-51.
80. Bennett MV, Barrio LC, Bargiello TA, Spray DC, Hertzberg E, Saez JC. Gap junctions: new tools, new answers, new questions. Neuron. 1991;6: 305-20.
81. Evans WH, De Vuyst E, Leybaert L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem J. 2006;397: 1-14.
82. Hansen KA, Torborg CL, Elstrott J, Feller MB. Expression and function of the neuronal gap junction protein connexin 36 in developing mammalian retina. J Comp Neurol. 2005;493: 309-20.
83. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci U S A. 2003;100: 13644-9.
84. Ray A, Zoidl G, Weickert S, Wahle P, Dermietzel R. Site-specific and developmental expression of pannexin1 in the mouse nervous system. Eur J Neurosci. 2005;21: 3277-90.
85. Zoidl G, Petrasch-Parwez E, Ray A, Meier C, Bunse S, Habbes HW, et al. Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus. Neuroscience. 2007;146: 9-16.
86. Vogt A, Hormuzdi SG, Monyer H. Pannexin1 and Pannexin2 expression in the developing and mature rat brain. Brain Res Mol Brain Res. 2005;141: 113-20.
87. Orellana JA, Martinez AD, Retamal MA. Gap junction channels and hemichannels in the CNS: regulation by signaling molecules. Neuropharmacology. 2013.
88. Kimelberg HK, Sankar P, O'Connor ER, Jalonen T, Goderie SK. Functional consequences of astrocytic swelling. Prog Brain Res. 1992;94: 57-68.
89. Wu Z, Xu H, He Y, Yang G, Liao C, Gao W, et al. Antisense oligodeoxynucleotides targeting connexin43 reduce cerebral astrocytosis and edema in a rat model of traumatic brain injury. Neurol Res. 2013;35: 255-62.
90. Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junction hemichannels. Science. 2006;312: 924-7.
91. Takeuchi H, Jin S, Suzuki H, Doi Y, Liang J, Kawanokuchi J, et al. Blockade of microglial glutamate release protects against ischemic brain injury. Exp Neurol. 2008;214: 144-6.
92. de Pina-Benabou MH, Szostak V, Kyrozis A, Rempe D, Uziel D, Urban-Maldonado M, et al. Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia. Stroke. 2005;36: 2232-7.
93. Bargiotas P, Krenz A, Hormuzdi SG, Ridder DA, Herb A, Barakat W, et al. Pannexins in ischemia-induced neurodegeneration. Proc Natl Acad Sci U S A. 2011;108: 20772-7.
94. Owsianik G, D'Hoedt D, Voets T, Nilius B. Structure-function relationship of the TRP channel superfamily. Rev Physiol Biochem Pharmacol. 2006;156: 61-90.
95. Latorre R. Perspectives on TRP channel structure and the TRPA1 puzzle. J Gen Physiol. 2009;133: 227-9.
96. Minke B. Drosophila mutant with a transducer defect. Biophys Struct Mech. 1977;3: 59-64.
97. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J. 2009;23: 297-328.
98. Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, et al. A key role for TRPM7 channels in anoxic neuronal death. Cell. 2003;115: 863-77.
99. Butenko O, Dzamba D, Benesova J, Honsa P, Benfenati V, Rusnakova V, et al. The increased activity of TRPV4 channel in the astrocytes of the adult rat hippocampus after cerebral hypoxia/ischemia. PLoS One. 2012;7: e39959.
100. Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst. 2010;102: 1052-68.
101. Tai Y, Feng S, Ge R, Du W, Zhang X, He Z, et al. TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway. J Cell Sci. 2008;121: 2301-7.
102. Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, Paul L, et al. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res. 2010;70: 418-27.
103. Phelan KD, Shwe UT, Abramowitz J, Wu H, Rhee SW, Howell MD, et al. Canonical transient receptor channel 5 (TRPC5) and TRPC1/4 contribute to seizure and excitotoxicity by distinct cellular mechanisms. Mol Pharmacol. 2013;83: 429-38.
104. Jia Y, Zhou J, Tai Y, Wang Y. TRPC channels promote cerebellar granule neuron survival. Nat Neurosci. 2007;10: 559-67.
105. Du W, Huang J, Yao H, Zhou K, Duan B, Wang Y. Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats. J Clin Invest. 2010;120: 3480-92.
106. Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. Mediation of neuronal apoptosis by Kv2. 1-encoded potassium channels. J Neurosci. 2003;23: 4798-802.
107. Redman PT, He K, Hartnett KA, Jefferson BS, Hu L, Rosenberg PA, et al. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2. 1. Proc Natl Acad Sci U S A. 2007;104: 3568-73.
108. Jehle J, Schweizer PA, Katus HA, Thomas D. Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis. 2: e193.
109. Jessica Chen M, Sepramaniam S, Armugam A, Shyan Choy M, Manikandan J, Melendez AJ, et al. Water and ion channels: crucial in the initiation and progression of apoptosis in central nervous system? Curr Neuropharmacol. 2008;6: 102-16.
110. Calloe K, Nielsen MS, Grunnet M, Schmitt N, Jorgensen NK. KCNQ channels are involved in the regulatory volume decrease response in primary neonatal rat cardiomyocytes. Biochim Biophys Acta. 2007;1773: 764-73.
111. Zhou X, Wei J, Song M, Francis K, Yu SP. Novel role of KCNQ2/3 channels in regulating neuronal cell viability. Cell Death Differ. 18: 493-505.
112. Weston AH, Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol. 1992;43: 47-54.
113. Gensini GF, Simone I, Pantoni L, Inzitari D. Large trials in the secondary prevention of stroke. Ann Ital Med Int. 1996;11 Suppl 2: 102S-9S.
114. Wei N, Yu SP, Gu XH, Chen DD, Whalin MK, Xu GL, Liu XF, Wei L. The involvement of autophagy pathway in exaggerated ischemic brain damage in diabetic mice. CNS Neurosci Ther. 2013.
115. Yacobi-Sharon K, Namdar Y, Arama E. Alternative germ cell death pathway in Drosophila involves HtrA2/Omi, lysosomes, and a caspase-9 counterpart. Dev Cell. 2013;25: 29-42.
116. Chaabane W, User SD, El-Gazzah M, Jaksik R, Sajjadi E, Rzeszowska-Wolny J, et al. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch Immunol Ther Exp (Warsz). 2013;61: 43-58.
117. Puyal J, Ginet V, Grishchuk Y, Truttmann AC, Clarke PG. Neuronal autophagy as a mediator of life and death: contrasting roles in chronic neurodegenerative and acute neural disorders. Neuroscientist. 2012;18: 224-36.
118. Pantoni L, Moretti M, Inzitari D. The first Italian report on "Binswanger's disease". Ital J Neurol Sci. 1996;17: 367-70.
119. Pantoni L, Garcia JH, Brown GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci. 1996;135: 131-9.
120. Linkermann A, Hackl MJ, Kunzendorf U, Walczak H, Krautwald S, Jevnikar AM. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant. 2013.
121. Tischner D, Manzl C, Soratroi C, Villunger A, Krumschnabel G. Necrosis-like death can engage multiple pro-apoptotic Bcl-2 protein family members. Apoptosis. 2012;17: 1197-209.
122. Gong J, Kumar SA, Graham G, Kumar AP. FLIP: Molecular switch between apoptosis and necroptosis. Mol Carcinog. 2013.
123. Bonnet MC, Bagot M, Bensussan A. Apoptotic and necroptotic cell death in cutaneous inflammation. Eur J Dermatol. 2013.
124. Chan FK. Fueling the flames: Mammalian programmed necrosis in inflammatory diseases. Cold Spring Harb Perspect Biol. 2012;4.
125. Dickens LS, Powley IR, Hughes MA, MacFarlane M. The 'complexities' of life and death: death receptor signalling platforms. Exp Cell Res. 2012;318: 1269-77.
126. Oerlemans MI, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, Sluijter JP. Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol. 2013;165: 410-22.
127. Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol. 2011;12: 1143-9.
128. Vanlangenakker N, Vanden Berghe T, Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ. 2012;19: 75-86.
129. Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P, et al. Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol. 2011;289: 1-35.
130. Smith CC, Yellon DM. Necroptosis, necrostatins and tissue injury. J Cell Mol Med. 2011;15: 1797-806.
131. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 2007;54: 34-66.
132. Webster KA. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 2012;8: 863-84.
133. Xu M, Zhang HL. Death and survival of neuronal and astrocytic cells in ischemic brain injury: a role of autophagy. Acta Pharmacol Sin. 2011;32: 1089-99.